• some image

About Us

Memcine Pharmaceuticals Inc. is an early-stage, biotech company focused on enhancing vaccine efficacy to improve human and animal health globally. Our current portfolio of potential infectious disease vaccine targets includes influenza, HepB, and Ebola. We have also conducted pre-clinical experiments in a mouse model of breast cancer, where our vaccine technology showed considerable promise as a therapeutic treatment.

Our pipeline is based on Memcine’s Immunoplex™ technology platform,which is designed to use the body’s own naturally occurring targeting system to deliver vaccine components to immune cells and stimulate a robust response.